Skip to search formSkip to main contentSkip to account menu

Strattera

a drug used to treat attention deficit hyperactivity disorder (ADHD)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
OBJECTIVE To study the association of microRNA expression before and after drug therapy with clinical symptoms in children with… 
Review
2018
Review
2018
Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most common behavioral health concerns in children and adolescents… 
2017
2017
FDA has approved the first generic versions of Strattera (atomoxetine) for the treatment of attention deficit/hyperactivity… 
2014
2014
To raise awareness, this article provides a commentary on the frequent underdosing of atomoxetine for the treatment of adult… 
2012
2012
An article published in the Fall 2004 issue and updated in the Spring 2006 issue of this journal discussed a recently approved… 
2010
2010
Children and adolescents (25 boys, nine girls, aged from six to 17 years) with attention deficit hyperactivity disorder (ADHD… 
Review
2008
Review
2008
539 ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) is a chronic condition. The prevalence of ADHD is estimated at 3–7% in… 
2008
2008
Therapeutic effect of atomoxetine and piracetam has been assessed in the open controlled study included 42 patients with…